gvtcx

NHS E South (Wessex) - Diabetic Eye Screening Programme ITT

South, Central and West Commissioning Support Unit Published 8 Jun 2016 Contracts Finder

key details

Value£15,655,000
Statuscomplete
Category (CPV) 85100000
Deadline18 Jul 2016
Contract start1 Apr 2017
Contract end31 Mar 2021
Procedureopen
SME suitableYes
OCIDocds-b5fd17-888c8618-acdc-49eb-9641-c6c7dc5a6302

Award

SupplierValueDateStatus
Health Intelligence £11,737,000 10 Oct 2016 active

description

AWARD NOTICE

NHS England South (Wessex) (the Commissioner) were seeking to commission a Diabetic Eye Screening Programme service for patients in Lot 1: North and West Hampshire, Southampton and Isle of Wight and Lot 2: Dorset. The procurement was carried out by NHS South, Central & West Commissioning Support Unit (SCWCSU) on behalf of the Commissioners".

The Commissioner were looking for a provider(s) to deliver a high quality service across Dorset, North and West Hampshire, Southampton and Isle of Wight. The aim of the NDESP is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment if necessary of sight threatening diabetic retinopathy. In line with the national specification the screening programme must operate a 12 month screening interval for all people with diabetes invited for routine digital screening plus digital surveillance clinics for individuals who require more frequent screening. The Commissioners would like to encourage innovative solutions which will deliver value for money and improved services to patients.

The Commissioners were seeking from suitably qualified and experienced providers including third sector and social enterprise organisations, private and NHS to provide the NHS Diabetic Eye Screening Programme (NDESP) to patients living and registered in Dorset, North and West Hampshire, Southampton and Isle of Wight.

The aim of the contract is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment if necessary of sight threatening diabetic retinopathy, at the appropriate stage during the disease process.

This will be achieved by delivering evidence-based, population-based screening programmes that:

identify the eligible population and ensure effective delivery with maximum coverage
are safe, effective, of a high quality, externally and independently monitored, and quality assured
lead to earlier detection, appropriate referral, effective treatment and improved outcomes
are delivered and supported by suitably trained, competent, and qualified, clinical and non-clinical staff who, where relevant, participate in recognised on-going CME, Continuous Professional Development (CPD), and Quality Assurance (QA) schemes
have audit embedded in the service.

The contract duration will be 4 years and will commence on 1st April 2017.

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
22 Dec 2016 Award (award) · 360e3b7e-83fa-49ea-8361-c076fc022059-122552

more from South, Central and West Commissioning Support Unit

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.